BMB Reports

Korean Society for Biochemistry and Molecular Biology (생화학분자생물학회)
권호 표지

Regulation of Taurine Transporter Activity by Glucocorticoid Hormone

  • Kim, Ha-Won (Department of Life Science, College of Liberal Arts and Natural Science, Seoul City University) ;
  • Shim, Mi-Ja (Department of Life Science, College of Liberal Arts and Natural Science, Seoul City University) ;
  • Kim, Won-Bae (Research Laboratories, Dong-A Pharmaceutical Co., Ltd.) ;
  • Kim, Byong-Kak (College of Pharmacy, Seoul National University)
  • Received : 1995.08.10
  • Published : 1995.11.30
Download PDF
⟨ Previous Next ⟩

Abstract

Human taurine transporter has 12 transmembrane domains and its molecular weight is 69.6 kDa. The long cytoplasmic carboxy and amino termini might function as regulatory attachment sites for other proteins. Six potential protein kinase C phosphorylation sites have been reported in human taurine transporter. In this report, we studied the effects of phorbol 12-myristate 13-acetate (PMA) and glucocorticoid hormone on taurine transportation in the RAW 264.7, mouse macrophage cell line. When the cells were incubated with $[^{3}H]taurine$ in the presence or absence of $Na^+$ ion for 40 min at $37^{\circ}C$, the [$[^{3}H]taurine$ uptake rate was 780-times higher in the $Na^{+}-containing$ buffer than in the $Na^{+}-deficient$ buffer, indicating that this cell line expresses taurine transporter protein on the cell surface. THP1, a human promonocyte cell line, also showed a similar property. The $[^{3}H]taurine$ uptake rate was not influenced by the inflammatory inducing cytokines such as interleukin-1, gamma-interferon or interleukin-1+gamma-interferon, but was decreased by the PMA in the RAW 264.7 cell line. This suggests that activation of protein kinase C inhibits taurine transporter activity directly or indirectly. The inhibition of $[^{3}H]taurine$ uptake by PMA was time-dependent. Maximal inhibition occurred in one hr stimulation with PMA Increasing the treatment time beyond one h reduced the $[^{3}H]taurine$ uptake inhibition due to the depletion or inactivation of protein kinase C. The cell line also showed concentration-dependent $[^{3}H]taurine$ uptake under PMA stimulation. The phorbol-ester caused 23% inhibition at the concentration of 1 ${\mu}m$ PMA. The inhibition was significant even at a concentration as low as 10 nM PMA The reduced $[^{3}H]taurine$ uptake could be recovered by treatment with glucocorticosteroid hormone. Dexamethasone led to recover of the reduced taurine uptake induced by phorbol-ester, recovering maximally after one hr. This may suggest that macrophage cells require higher taurine concentration in a stressed state, for the secretion of glucocorticoid hormone is increased by hypothalamo-pituitary-adrenocortical (HPA) axis activation in the blood stream.

Keywords

References

  1. Taurine, Nutritional Values and Mechanisms of Action Banks, M.A.;Porter, D.W.;Martin, W.G.;Castranova, V.;Lombardini, J.B.(ed.);Schaffer, S.W.(ed.);Azuma, J.(ed.)
  2. Cancer Res. v.48 Blumberg, P.M.
  3. Taurine: Functional Neurochemistry, Physiology and Cardiology Boxter, C.F.;Baldwin, R.A.;Oh, C.C.
  4. Am. J. Physiol. v.264 no.5 Brandsch, M.;Miyamoto, Y.;Ganapathy, V.;Leibach, H.H.
  5. Immunol. Today v.13 no.8 Goulding, N.J.;Guyre, P.M. https://doi.org/10.1016/0167-5699(92)90040-E
  6. Curr. Opinion in Immunol. v.5 Goulding, N.J.;Guyre, P.M. https://doi.org/10.1016/0952-7915(93)90089-B
  7. Abstracts of International Taurine Symposium '95 Han, X.;Chesney, R.W.;Budreau, A.M.;Jones, D.P.
  8. Abstracts of International Taurine Symposium '95 Han, X.;Budreau, A.M.;Jones, D.P.;Chesney, R.W.
  9. J. Cellular Physiol. v.149 no.1 Hass, R.;Brach, M.;Kharbanda, S.;Giese, G.;Traub, P.;Kufe, D. https://doi.org/10.1002/jcp.1041490116
  10. Taurine:Functional Neurochemistry, Physiology and Cardiology Iwada, H.;Koyama, Y.;Uemura, A.;Tanaka, H.;Noda, M.;Baba, A.
  11. FEBS Letters v.318 Jhiang, S.M.;Fithian, L.;Smanik, P.;McGill, J.;Tong, Q.;Mazzaferri, E.L. https://doi.org/10.1016/0014-5793(93)80008-I
  12. J. Am. Soc. Nephrol. v.2 no.5 Jones, D.P.;Miller, L.A.;Dowling, C.;Chesney, R.W.
  13. Biochem. J. v.277 Kulanthaivel, P.;Cool, D.R.;Ramamoorthy, S.;Mahesh, V.B.;Leibach, F.H.;Ganapathy, V. https://doi.org/10.1042/bj2770053
  14. Taurine : Functional Neurochemistry, Physiology and Cardiology Lambert, I.H.;Hoffman, E.K.
  15. Proc. Natl. Acad. Sci. USA v.89 Liu, Q.R.;Lopez-Corcuera, B.;Nelson, H.;Mandiyan, S.;Nelson, N. https://doi.org/10.1073/pnas.89.24.12145
  16. Cell Signalling Morgan, N.G.
  17. J. Leukocyte Biol. v.54 no.2 Park, E.;Quinn, M.R.;Wright, C.E.;Schuller-Levis, G. https://doi.org/10.1002/jlb.54.2.119
  18. Br. J. Pharmacol. v.108 Peers, S.H.;Smillie, F.;Elderfield, A.J.;Flower, R.J. https://doi.org/10.1111/j.1476-5381.1993.tb13441.x
  19. Biochim. Biophys. Acta v.1145 no.2 Ramamoorthy, S.;Kulanthaivel, P.;Leibach, F.H.;Mahesh, V.B.;Ganapathy, V. https://doi.org/10.1016/0005-2736(93)90296-C
  20. Biochem. J. v.300 Ramamoorthy, S.;Leibach, F.H.;Mahesh, V.B.;Han, H.;Yang-Feng, T.;Blakely, R.D.;Ganapathy, V. https://doi.org/10.1042/bj3000893
  21. Mol. Pharmacol. v.42 Smith, K.E.;Borden, L.A.;Wang, C.D.;Hartig, P.R.;Branchek, T.A.;Weinshank, R.L.
  22. Am. J. Physiol. v.263 Tiruppathi, C.;Brandsch, M.;Miyamoto, Y.;Ganapathy, V.;Leibach, F.H.
  23. Proc. Natl. Acad. Sci. USA v.89 Uchida, S.;Kwon, H.M.;Yamauchi, A.;Preston, A.S.;Marumo, F.;Handler, J.S. https://doi.org/10.1073/pnas.89.17.8230
  24. Annu. Rev. Biochem. v.55 Wright, C.E.;Tallan, H.H.;Lin, Y.Y. https://doi.org/10.1146/annurev.bi.55.070186.002235
  25. Taurine: Functional Neurochemistry, Physiology and Cardiology Wu, J.;Liao, C.;Lin, C.J.;Lee, Y.H.;Ho, J.Y.;Tsai, W.H.;Pasantes-Morales, H.(ed.);Shain, W.(ed.)Martin, D.L.(ed.);Rio, R.M.(ed.)